Dimora Medical Distributes Wound Care Products in Houston
The firm is targeting the hidradenitis suppurativa market by placing silicone foam dressings directly into the hands of end-users.
Updated on Oct. 23, 2026 in Healthcare

Dimora Medical sponsored the HS Connect Empower Conference 2026, where the firm distributed silicone foam dressings to attendees in Houston. The company provided the medical-grade products to patients, caregivers, and healthcare professionals to support the at-home management of exuding wounds.
Why it matters
The distribution reflects a strategic focus by medical device manufacturers on direct-to-patient engagement within the hidradenitis suppurativa community. By providing samples to end-users and caregivers, the company aims to establish brand presence in the specialized market for wound care supplies.
Dimora Medical utilized the 2026 HS Connect Empower Conference for product distribution to patients and clinical professionals. The scale of this outreach follows the company goal of supporting at-home wound management, though total product quantities remain unconfirmed.
The players
Dimora Medical
A developer of specialized wound care products focused on addressing chronic skin conditions through advanced materials.
The details
Dimora Medical incorporated its silicone foam dressings featuring MegaSorb technology directly into conference attendee gift bags. This distribution mechanism places product samples into the hands of both professional clinicians and the patients managing exuding wounds at home. The approach serves to bypass traditional procurement channels for initial product familiarization and usage.
Timeline
October 16-17, 2026: The HS Connect Empower Conference 2026 took place in Houston.
Market Landscape
The HS Connect Empower Conference functions as an essential nexus for specialized wound care manufacturers to reach end-users. This engagement follows a broader industry trend where device firms prioritize direct patient interaction to differentiate themselves in the chronic care market.
Operators in the home health and wound care supply space should track how direct-to-patient sampling impacts product adoption rates and clinician recommendations. Evaluating the efficacy of gift-bag distributions against traditional sales rep models can help optimize market entry and growth strategies.
The takeaway
Direct patient access is increasingly vital for medical firms looking to capture market share in chronic condition management. Owners should monitor how these outreach tactics influence the preferred product lists of their clinical staff or supply procurement departments.
Further reading
For broader trends in medical product distribution, explore the Healthcare section.









